期刊文献+

和厚朴酚在缓冲溶液HBSS中的溶解性和稳定性 被引量:2

Study on Solubility and Stability of Honokiol in Buffer Solution of HBSS
原文传递
导出
摘要 目的:考察和厚朴酚在HBSS溶液中的溶解性和稳定性,为和厚朴酚在体内的吸收与代谢研究提供依据。方法:采用RP-HPLC法,分别考察了pH、温度、光照对和厚朴酚溶解性和稳定性的影响。结果:和厚朴酚在甲醇的标准曲线为Y=4 764.5X-10 955(r=0.999),在4~200μmol·L-1与峰面积呈良好的线性关系,检测限为0.2μmol·L-1,精密度和稳定性符合要求。和厚朴酚在含有1%甲醇和0.1%的吐温-80的HBSS中的溶解性较好,和厚朴酚在酸性中的稳定性优于碱性环境,在pH 7.4的HBSS中的稳定性比较理想,光照对和厚朴酚的稳定性没有影响。结论:和厚朴酚在pH 7.4的HBSS中的溶解性和稳定性比较理想,当其达到溶解平衡之后于-20℃储存。 Objective:To investigate the solubility and stability of honokiol in HBSS,Establish the basis of the drug metabolism research.Method:The concentration of honokiol was determined by RP-HPLC method,pH,temperatures and light were investigated on the solubility and stability of honokiol.Result:The linear calibration curve of Honokiol in methanol in the concentration range of 4-200 μmol·L^-1 with a detection limit of 0.2 μmol /L,The equation was calculated to be Y = 4 764.5X-10 955(r=0.999),The precision and stability accorded with the requirements of methodology.The solubility of honokiol is good in HBSS containing 1% methanol and 0.1% Tween-80,the stability of honokiol in HBSS of acidic is more better than HBSS of alkaline,.light on the stability of honokiol has no influence.Conclusion:Tthe solubility and stability of honokiol in HBSS of pH 7.4 is rather ideal,when it reached the dissolution equilibrium it should be storied at-20 ℃.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第13期90-93,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 国家科技支撑计划项目子课题(2006BAI11B08-04)
关键词 和厚朴酚 溶解性 稳定性 RP—HPLC honokiol solubility stability RP-HPLC
  • 相关文献

参考文献7

  • 1张建和,符伟玉,莫丽儿.中药厚朴及其提取工艺的研究概况[J].时珍国医国药,2004,15(5):313-314. 被引量:23
  • 2Teng C M,Yu S M,Chen C C,et al.EDRF2 release and Ca2+-channel blockade by honokiol,an antiplatelet agent isolated from Chinese herb Magnolia officinalis,in rat thoracic aorta[J].Life Sci,1990,47(13):1153.
  • 3国家药典委员会.中国药典[S].北京:中国医药科技出版社,2010:550.
  • 4Teófilo Vasconcelos,Bruno Sarmento,Paulo Costa.Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs[J].Drug Discovery Today,2007,12(23/24):1068.
  • 5S Rawat,S K Jain.Rofecoxib-β-cyclodextrin inclusion complex for solubility enhancement[J].Pharmazie,2003,58(9):639.
  • 6郑艳,杨秀伟.茯苓酸在人源肠Caco-2细胞单层模型的吸收和转运(英文)[J].中西医结合学报,2008,6(7):704-710. 被引量:10
  • 7Xuanqiang Yu,Gail L Zipp,G W Bay Davidson Ⅲ.The effect of temperature and pH on the solubility of quinolone compounds:estimation of heat of fusion[J].Pharm Res,1994,4(11):522.

二级参考文献39

共引文献347

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部